Home
>
National Drug Code (NDC)
>
CLONAZEPAM
CLONAZEPAM - 57664-275-13 - (CLONAZEPAM)
Drug Information of CLONAZEPAM
| Product NDC: | 57664-275 |
| Proprietary Name: | CLONAZEPAM |
| Non Proprietary Name: | CLONAZEPAM |
| Active Ingredient(s): | 2 mg/1 & nbsp; CLONAZEPAM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CLONAZEPAM
| Product NDC: | 57664-275 |
| Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075423 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20010831 |
Package Information of CLONAZEPAM
| Package NDC: | 57664-275-13 |
| Package Description: | 500 TABLET in 1 BOTTLE (57664-275-13) |
NDC Information of CLONAZEPAM
| NDC Code | 57664-275-13 |
| Proprietary Name | CLONAZEPAM |
| Package Description | 500 TABLET in 1 BOTTLE (57664-275-13) |
| Product NDC | 57664-275 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CLONAZEPAM |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20010831 |
| Marketing Category Name | ANDA |
| Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
| Substance Name | CLONAZEPAM |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |
